Tallapalli, P.S.; Reddy, Y.D.; Yaraguppi, D.A.; Matangi, S.P.; Challa, R.R.; Vallamkonda, B.; Ahmad, S.F.; Al-Mazroua, H.A.; Rudrapal, M.; Dintakurthi Sree Naga Bala Krishna, P.;
et al. In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase. Pharmaceuticals 2024, 17, 1093.
https://doi.org/10.3390/ph17081093
AMA Style
Tallapalli PS, Reddy YD, Yaraguppi DA, Matangi SP, Challa RR, Vallamkonda B, Ahmad SF, Al-Mazroua HA, Rudrapal M, Dintakurthi Sree Naga Bala Krishna P,
et al. In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase. Pharmaceuticals. 2024; 17(8):1093.
https://doi.org/10.3390/ph17081093
Chicago/Turabian Style
Tallapalli, Partha Saradhi, Yennam Dastagiri Reddy, Deepak A. Yaraguppi, Surya Prabha Matangi, Ranadheer Reddy Challa, Bhaskar Vallamkonda, Sheikh F. Ahmad, Haneen A. Al-Mazroua, Mithun Rudrapal, Prasanth Dintakurthi Sree Naga Bala Krishna,
and et al. 2024. "In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase" Pharmaceuticals 17, no. 8: 1093.
https://doi.org/10.3390/ph17081093
APA Style
Tallapalli, P. S., Reddy, Y. D., Yaraguppi, D. A., Matangi, S. P., Challa, R. R., Vallamkonda, B., Ahmad, S. F., Al-Mazroua, H. A., Rudrapal, M., Dintakurthi Sree Naga Bala Krishna, P., & Pasala, P. K.
(2024). In Silico and In Vivo Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase. Pharmaceuticals, 17(8), 1093.
https://doi.org/10.3390/ph17081093
